Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
31 hedge funds and large institutions have $16.6M invested in Apollo Endosurgery, Inc. in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
0% more funds holding
Funds holding: 31 → 31 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
31% less capital invested
Capital invested by funds: $24M → $16.6M (-$7.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$467K |
| 2 |
CI
CPMG Inc
Dallas,
Texas
|
+$150K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$100K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$85.4K |
| 5 |
PC
PA Capital
Richmond,
Virginia
|
+$57.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$212K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$31K |
| 3 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$14.9K |
| 4 |
BlackRock
New York
|
-$4.06K |
| 5 |
RWA
Ropes Wealth Advisors
Boston,
Massachusetts
|
-$2K |
APEN Hedge Fund Activity: Q1 2020 in Review
31 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2020, worth a combined $16.6M — down 31% from $24M a quarter earlier.
Fund positioning in APEN was balanced in Q1 2020: 3 funds opened new positions, 3 closed out, 9 added to existing stakes and 2 trimmed.
The largest buyer was Prosight Management, adding an estimated $467K. The largest seller was Russell Investments Group, exiting entirely with an estimated $212K sold.
- 31 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $16.6M of Apollo Endosurgery, Inc. stock for Q1 2020, down 31% quarter-over-quarter.
- 3 funds opened new Apollo Endosurgery, Inc. positions in Q1 2020 and 3 closed out, a net change of 0 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2020 was Prosight Management, an estimated $467K added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2020 was Russell Investments Group, an estimated $212K sold.
Based on aggregated 13F filings for Q1 2020.